MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells

References

• Weatherall DJ. The evolving spectrum of the epidemiology of thalassemia. Hematol Oncol Clin North Am. 2018;32:165–175.
   PubMed Web of Science ®Google Scholar
• Sahin A, Er EO, Oz E, et al. Sodium, magnesium, calcium, manganese, iron, copper, and zinc in serums of beta thalassemia major patients. Biol Trace Elem Res. 2021;199:888–894.
   PubMed Web of Science ®Google Scholar
• El-Tagui MH, Salama KM, El-Sabbagh MH, et al. Polyneuropathy associated with severe iron overload and oxidative stress in beta-thalassemia patients. Indian J Hematol Blood Transfus. 2019;35:518–522.
   PubMed Web of Science ®Google Scholar
• Mirlohi MS, Yaghooti H, Shirali S, et al. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major. Ann Hematol. 2018;97:679–684.
   PubMed Web of Science ®Google Scholar
• Wienert B, Martyn GE, Funnell APW, et al. Wake-up sleepy gene: reactivating fetal globin for beta-hemoglobinopathies. Trends Genet. 2018;34:927–940.
   PubMed Web of Science ®Google Scholar
• Liu N, Hargreaves VV, Zhu Q, et al. Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell. 2018;173:430–442.
   PubMed Web of Science ®Google Scholar
• Pullarkat V, Meng Z, Tahara SM, et al. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway. Hemoglobin. 2014;38:188–195.
   PubMed Web of Science ®Google Scholar
• Dulmovits BM, Appiah-Kubi AO, Papoin J, et al. Pomalidomide reverses gamma-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. Blood. 2016;127:1481–1492.
   PubMed Web of Science ®Google Scholar
• Grevet JD, Lan X, Hamagami N, et al. Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells. Science. 2018;361:285–290.
   PubMed Web of Science ®Google Scholar
• Yu X, Azzo A, Bilinovich SM, et al. Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells. Haematologica. 2019;104:2361–2371.
   PubMed Web of Science ®Google Scholar
• Bjurstrom CF, Mojadidi M, Phillips J, et al. Reactivating fetal hemoglobin expression in human adult erythroblasts through BCL11A knockdown using targeted endonucleases. Mol Ther Nucleic Acids. 2016;5:e351.
   PubMedGoogle Scholar
• Chang KH, Smith SE, Sullivan T, et al. Long-Term engraftment and fetal globin induction upon BCL11A gene editing in bone-marrow-derived CD34(+) hematopoietic stem and progenitor cells. Mol Ther Methods Clin Dev. 2017;4:137–148.
   PubMed Web of Science ®Google Scholar
• Li SH, Li JP, Chen L, et al. miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A. Med Hypotheses. 2018;117:21–27.
   PubMed Web of Science ®Google Scholar
• Kretov DA, Walawalkar IA, Mora-Martin A, et al. Ago2-Dependent processing allows miR-451 to evade the global MicroRNA turnover elicited during erythropoiesis. Mol Cell. 2020;78:317–328.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu D, Zhang X, et al. miR-326 regulates HbF synthesis by targeting EKLF in human erythroid cells. Exp Hematol. 2018;63:33–40. e32.
   PubMed Web of Science ®Google Scholar
• Ward CM, Li B, Pace BS. Original research: stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells. Exp Biol Med (Maywood). 2016;241:719–729.
   PubMed Web of Science ®Google Scholar
• Lessard S, Beaudoin M, Orkin SH, et al. 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts. Hum Mol Genet. 2018;27:1411–1420.
   PubMed Web of Science ®Google Scholar
• Wang F, Ling L, Yu D. MicroRNAs in beta-thalassemia. Am J Med Sci. 2021;362:5–12.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Qi P, et al. Biology of MiR-17-92 cluster and its progress in lung cancer. Int J Med Sci. 2018;15:1443–1448.
   PubMed Web of Science ®Google Scholar
• Li Y, Vecchiarelli-Federico LM, Li YJ, et al. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood. 2012;119:4486–4498.
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Itoh S, Fukazawa Y, et al. Association between oxidative stress and microRNA expression pattern of ALS patients in the high-incidence area of the Kii peninsula. Brain Res. 2020;1746:147035.
   PubMed Web of Science ®Google Scholar
• Gan X, Zhao H, Wei Y, et al. Role of miR-92a-3p, oxidative stress, and p38MAPK/NF-kappaB pathway in rats with central venous catheter related thrombosis. BMC Cardiovasc Disord. 2020;20:150.
   PubMed Web of Science ®Google Scholar
• Cui J, Ding H, Yao Y, et al. Inhibition Mir-92a alleviates oxidative stress and apoptosis of alveolar epithelial cells induced by lipopolysaccharide exposure through TLR2/AP-1 pathway. Biomed Res Int. 2020;2020:9673284.
   PubMed Web of Science ®Google Scholar
• Felli N, Cianetti L, Pelosi E, et al. Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol. 2010;4:85.
   PubMed Web of Science ®Google Scholar
• Gabbianelli M, Testa U, Massa A, et al. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood. 2000;95:3555–3561.
   PubMed Web of Science ®Google Scholar
• Liu N, Xu S, Yao Q, et al. Transcription factor competition at the gamma-globin promoters controls hemoglobin switching. Nat Genet. 2021;53:511–520.
   PubMed Web of Science ®Google Scholar
• Perconti G, Rubino P, Contino F, et al. RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets. BMC Bioinformatics. 2019;20:120.
   PubMed Web of Science ®Google Scholar
• Fibach E, Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia - an update. F1000Res. 2017;6:2156.
   PubMedGoogle Scholar
• Fibach E, Rachmilewitz EA. Iron overload in hematological disorders. Presse Med. 2017;46:e296–e305.
   PubMed Web of Science ®Google Scholar
• Razak SAA, Murad NAA, Masra F, et al. Genetic modifiers of fetal haemoglobin (HbF) and phenotypic severity in beta-thalassemia patients. Curr Mol Med. 2018;18:295–305.
   PubMed Web of Science ®Google Scholar
• Basak A, Sankaran VG. Regulation of the fetal hemoglobin silencing factor BCL11A. Ann N Y Acad Sci. 2016;1368:25–30.
   PubMed Web of Science ®Google Scholar
• Li B, Zhu X, Ward CM, et al. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease. Exp Hematol. 2019;70:85–96.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Shang X, Chen D, et al. MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6. Br J Haematol; 2021;193:401–405.
   PubMed Web of Science ®Google Scholar
• Chaichompoo P, Qillah A, Sirankapracha P, et al. Abnormal red blood cell morphological changes in thalassaemia associated with iron overload and oxidative stress. J Clin Pathol. 2019;72:520–524.
   PubMed Web of Science ®Google Scholar
• Maia de Oliveira da Silva JP, Brugnerotto AF, Romanello KS, et al. Global gene expression reveals an increase of HMGB1 and APEX1 proteins and their involvement in oxidative stress, apoptosis and inflammation pathways among beta-thalassaemia intermedia and major phenotypes. Br J Haematol. 2019;186:608–619.
   PubMed Web of Science ®Google Scholar
• Xu Y, Miao C, Cui J, et al. miR-92a-3p promotes ox-LDL induced-apoptosis in HUVECs via targeting SIRT6 and activating MAPK signaling pathway. Braz J Med Biol Res. 2021;54:e9386.
   PubMed Web of Science ®Google Scholar
• Wen C, Ying Y, Zhao H, et al. Resistance exercise affects catheter-related thrombosis in rats through miR-92a-3p, oxidative stress and the MAPK/NF-kappaB pathway. BMC Cardiovasc Disord. 2021;21:440.
   PubMed Web of Science ®Google Scholar
• Martyn GE, Wienert B, Yang L, et al. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. Nat Genet. 2018;50:498–503.
   PubMed Web of Science ®Google Scholar
• Tolve M, Ulusoy A, Patikas N, et al. The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons. Cell Rep. 2021;36:109697.
   PubMed Web of Science ®Google Scholar
• Gholampour MA, Asadi M, Naderi M, et al. miR-30a regulates gamma-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A. Mol Biol Rep. 2020;47:3909–3918.
   PubMed Web of Science ®Google Scholar
• Gasparello J, Fabbri E, Bianchi N, et al. BCL11A mRNA targeting by miR-210: a possible network regulating gamma-globin gene expression. Int J Mol Sci. 2017;18:2530.
   PubMed Web of Science ®Google Scholar